KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

QuidelOrtho (QDEL) Gains from Investment Securities (2021 - 2025)

QuidelOrtho's Gains from Investment Securities history spans 5 years, with the latest figure at -$1.3 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 244.44% year-over-year to -$1.3 million; the TTM value through Dec 2025 reached $5.4 million, down 43.75%, while the annual FY2025 figure was $5.4 million, 43.75% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$1.3 million at QuidelOrtho, down from $4.7 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $2.4 billion in Q1 2023 and bottomed at -$3.0 million in Q4 2023.
  • The 5-year median for Gains from Investment Securities is $1.4 million (2024), against an average of $172.4 million.
  • The largest annual shift saw Gains from Investment Securities soared 9400.0% in 2023 before it plummeted 244.44% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at -$100000.0 in 2021, then skyrocketed by 200.0% to $100000.0 in 2022, then plummeted by 3100.0% to -$3.0 million in 2023, then soared by 130.0% to $900000.0 in 2024, then tumbled by 244.44% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for QDEL's Gains from Investment Securities are -$1.3 million (Q4 2025), $4.7 million (Q3 2025), and $2.0 million (Q2 2025).